Maternal diabetes and being born large for gestational age are linked to a significantly higher risk for adult-onset multiple sclerosis in offspring.

Chronic malabsorption syndromes such as Crohn disease, chronic pancreatitis, and short bowel syndrome are associated with an increased risk for AMD.

Some individuals with IBS meet the criteria for nonceliac gluten sensitivity and may find symptom improvement with a gluten-free diet.

The FDA expands Palynziq approval to include pediatric patients aged 12 years and older with phenylketonuria and uncontrolled blood Phe levels.

Dr Vinay Prasad will step down as the head of the Center for Biologics Evaluation and Research at the end of April to return to his faculty position at the University of California at San Francisco.

GLP-1 receptor agonist use was linked to a significantly higher risk for osteoporosis, gout, and osteomalacia over 5 years.

Initiation of GLP-1 receptor agonists was linked to fewer asthma exacerbations across overweight, obese, and morbidly obese patient cohorts.

Oral orforglipron demonstrated noninferiority and superiority to oral semaglutide for HbA1c reduction in adults with type 2 diabetes.

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

Trader Joe’s and Ajinomoto Foods voluntarily recalled frozen meals nationwide after multiple consumer complaints about glass in the products.

Robert F. Kennedy Jr announced a federal initiative in which 53 medical schools agreed to increase student nutrition education to 40 hours.

Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.